UK agency takes stock of better regulation scheme
This article was originally published in Scrip
Executive Summary
The MHRA, the UK medicines regulator, continues to "strip away unnecessary regulatory burdens in relation to medicines" through its four-year-old Better Regulation of Medicines Initiative (BROMI), it says in a progress report.